🔎 Trials Near Me

Gara Jalqabaatti › Kanisa Harkaa › Illinois › Chicago

Qorannoo klinikaalii Kanisa Harkaa Chicago, IL keessatti

Qorannoo 16 Kanisa Harkaa f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • fi 1 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • University of Illinois Cancer Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Namoota walitti qabaa jiraSadarkaa 2/3
  • Illinois Cancer Specialists, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07392892

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Illinois Cancer Center, Chicago
  • University of Chicago Medicine, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • University of Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT04107077

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • UChicago Medicine - River East, Chicago
  • The University Of Chicago, Chicago
  • University of Chicago Medical Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Namoota walitti qabaa jiraSadarkaa 1
  • University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
  • University of Chicago Medical Center /ID# 276271, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT05005403

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Chicago Medical Center, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06395519

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Northwestern University, Chicago
  • University of Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT06532006

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Chicago, Chicago
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 29-Ama-2026 · NCT06055439

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Chicago
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of Chicago, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Qorannoo Kanisa Harkaa magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.